Synopsys, Inc. (NASDAQ:SNPS) Shares Purchased by Foster Dykema Cabot & Partners LLC

Foster Dykema Cabot & Partners LLC lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 11.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 53,059 shares of the semiconductor company's stock after buying an additional 5,385 shares during the period. Synopsys makes up approximately 2.0% of Foster Dykema Cabot & Partners LLC's investment portfolio, making the stock its 17th biggest holding. Foster Dykema Cabot & Partners LLC's holdings in Synopsys were worth $25,753,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in SNPS. Kieckhefer Group LLC purchased a new stake in Synopsys during the fourth quarter worth $27,000. Whipplewood Advisors LLC purchased a new stake in shares of Synopsys during the 4th quarter worth about $33,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Synopsys during the 4th quarter worth about $34,000. Sierra Ocean LLC acquired a new stake in shares of Synopsys during the 4th quarter valued at about $39,000. Finally, Hazlett Burt & Watson Inc. increased its stake in shares of Synopsys by 28.6% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock valued at $44,000 after purchasing an additional 20 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Stock Down 0.6 %

Synopsys stock traded down $2.33 during trading on Friday, reaching $413.32. The stock had a trading volume of 1,002,399 shares, compared to its average volume of 1,091,245. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $624.80. The business has a 50 day moving average price of $446.35 and a 200 day moving average price of $495.10. The stock has a market cap of $63.91 billion, a PE ratio of 28.47, a P/E/G ratio of 3.23 and a beta of 1.23.

Analyst Ratings Changes

SNPS has been the topic of several research analyst reports. Rosenblatt Securities reiterated a "buy" rating and issued a $660.00 target price on shares of Synopsys in a research report on Tuesday, February 25th. KeyCorp cut their price objective on Synopsys from $690.00 to $555.00 and set an "overweight" rating for the company in a research note on Tuesday. Piper Sandler reduced their target price on Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Wells Fargo & Company lowered their price target on Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research note on Thursday, February 27th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $650.00 price objective on shares of Synopsys in a research note on Thursday, February 27th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $618.31.

Insider Activity at Synopsys

In related news, insider Geus Aart De sold 15,705 shares of the company's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the sale, the insider now owns 116,671 shares in the company, valued at $51,850,925.82. This represents a 11.86 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the sale, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at $32,890,077.50. The trade was a 13.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by corporate insiders.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.